Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients

Figure 1

Stroma evaluation for ER−PR−HER2− (TNBC) and ER+PR+HER2− breast cancer subtypes: (a) TNBC mammary carcinoma (40x): black star, viable tumor, hollow star, necrosis, and black arrow, heavy inflammation; (b) TNBC mammary carcinoma (400x): black arrow, desmoplastic stroma with moderate inflammation; (c) ER+PR+HER2− mammary carcinoma (400x): black arrow, fibrohyaline stroma, and black star, viable tumor; (d) TNBC mammary carcinoma (40x): black arrow, viable tumor, and black star, desmoplastic stroma.

(a)

(b)

(c)

(d)